Medication info
Frito Plus Tablet 80/12.5 mg

Frito Plus Tablet 80/12.5 mg

Prescription medicationTablet경구
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
광동제약(주)
Appearance
A rectangular tablet composed of two layers, white and red, with possible red speckles in the white layer.
Packaging
30 tablets/box [(10 tablets/PTP X 3)]
Approval status
Active

MFDS item code 200307775 · Approved 2003.02.25 · Insurance code 641806580

Summary

Main use
Treatment for hypertension
Who takes it
Adults · Children
Adult dose
The medication should be taken once daily with water, regardless of meals, in patients whose blood pressure is not adequately controlled with telmisartan alone. It is recommended to adjust the doses of individual components before switching to this fixed-dose combination medication. When clinically appropriate, switching directly from monotherapy to this medication may also be considered. - Telmisartan/Hydrochlorothiazide Combination 40/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 40 mg of telmisartan alone. - Telmisartan/Hydrochlorothiazide Combination 80/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 80 mg of telmisartan alone. - Telmisartan/Hydrochlorothiazide Combination 80/25 mg can be administered to patients whose blood pressure is not adequately controlled with either 80 mg of telmisartan or 12.5 mg of hydrochlorothiazide alone. Before initiating treatment with this medication, sodium or volume depletion should be corrected. Patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance <30 mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment: This medication should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5 mg. This medication should not be administered to patients with severe hepatic impairment (refer to precautions in usage 2). Thiazide diuretics should be administered with caution to patients with liver dysfunction. Elderly: No dose adjustment is necessary. Pediatrics: Safety and efficacy of this medication have not been established in children under 18 years old.
Child dose
Safety and efficacy of this medication have not been established in children under 18 years old.

Ingredients

Importer
광동제약(주)

Efficacy & effects

Treatment for hypertension

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension when blood pressure control with telmisartan alone is insufficient. This medicine effectively lowers blood pressure and helps reduce the risk of cardiovascular complications. It is used to stabilize patients’ blood pressure and improve health.

How to take

Adult dose

The medication should be taken once daily with water, regardless of meals, in patients whose blood pressure is not adequately controlled with telmisartan alone. It is recommended to adjust the doses of individual components before switching to this fixed-dose combination medication. When clinically appropriate, switching directly from monotherapy to this medication may also be considered. - Telmisartan/Hydrochlorothiazide Combination 40/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 40 mg of telmisartan alone. - Telmisartan/Hydrochlorothiazide Combination 80/12.5 mg can be administered to patients whose blood pressure is not adequately controlled with 80 mg of telmisartan alone. - Telmisartan/Hydrochlorothiazide Combination 80/25 mg can be administered to patients whose blood pressure is not adequately controlled with either 80 mg of telmisartan or 12.5 mg of hydrochlorothiazide alone. Before initiating treatment with this medication, sodium or volume depletion should be corrected. Patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance <30 mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment: This medication should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5 mg. This medication should not be administered to patients with severe hepatic impairment (refer to precautions in usage 2). Thiazide diuretics should be administered with caution to patients with liver dysfunction. Elderly: No dose adjustment is necessary. Pediatrics: Safety and efficacy of this medication have not been established in children under 18 years old.

Child dose

Safety and efficacy of this medication have not been established in children under 18 years old.

Precautions

This medication can severely harm the fetus if used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any component of this medication or have certain liver or kidney diseases should not use it. Elderly patients and those with certain heart, liver, or kidney diseases should use this medication cautiously, and their status should be monitored frequently during use. This medication lowers blood pressure, and symptoms of hypotension may occur, so caution is advised for dizziness or fainting. The hydrochlorothiazide component may cause electrolyte imbalances, and regular monitoring of potassium, sodium, and other blood levels is necessary. During treatment with this medication, increased sensitivity to sunlight may occur, so it is advisable to avoid sun exposure and to use appropriate protection if necessary. Since this medication interacts with many other drugs, particularly lithium, potassium-related medications, diuretics, and antihypertensives, patients should inform their doctor or pharmacist when taking these. Breastfeeding women are advised not to use this medication and should consult a specialist if needed. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may appear, requiring immediate medical attention. This medication is not recommended for children under 18 years old as safety and effectiveness have not been established.

Side effects and when to seek care immediately

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, severe skin adverse reactions, shortness of breath or difficulty in breathing, asthma attacks, respiratory disturbances accompanied by cough+fever, breathing problems, yellowing of the skin or eyes (jaundice), severe lethargy, liver abnormalities (jaundice), sudden

Mild side effects

  • Dizziness
  • diarrhea
  • cough
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
Show 25 more
  • insomnia
  • sleep disturbances
  • visual disturbances
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • respiratory discomfort
  • pneumonia
  • abdominal pain
  • constipation
  • indigestion
  • vomiting
  • hepatic dysfunction/hepatic impairment
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • low back pain
  • muscle cramps
  • myalgia
  • arthralgia
  • limb pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. Proper storage will help keep the medication's efficacy intact.

Appearance and packaging

Appearance

A rectangular tablet composed of two layers, white and red, with possible red speckles in the white layer.

Package unit

30 tablets/box [(10 tablets/PTP X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.